Feedback / Questions
carotuximab IV (ENV-105) - Kairos Pharma
https://www.businesswire.com/news/home/20251007913966/en/Kairos-Pharma-to-Present-Positive-Safety-and-Efficacy-Data-from-Phase-2-Prostate-Cancer-Trial-at-ESMO-2025
Oct 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next